Etonogestrel Administration Reduces the Expression of PHOX2B and Its Target Genes in the Solitary Tract Nucleus

Silvia Cardani1,2,3, Tara A Janes1,3, Jasmeen K Saini3,4

  • 1Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2E1, Canada.

Insights

A progestin drug, Etonogestrel, improved respiratory control in rats with Congenital Central Hypoventilation Syndrome by modulating PHOX2B expression in the brainstem. This offers a potential therapeutic avenue for this neurological disorder.

Area of Science:

  • Neuroscience
  • Respiratory Physiology
  • Pharmacology

Background:

  • Congenital Central Hypoventilation Syndrome (CCHS) is a rare neurological disorder caused by PHOX2B gene mutations, leading to impaired breathing.
  • Progestin drugs have shown potential in improving chemoreflex response in CCHS, but the underlying mechanism is unclear.
  • In vitro studies suggest a molecular link between progestins and PHOX2B expression.

Purpose of the Study:

  • To investigate the in vivo effects of Etonogestrel (ETO), a potent progestin, on respiratory function and PHOX2B expression in a rat model.
  • To identify the specific brain regions involved in ETO's therapeutic effects on respiratory control.

Main Methods:

  • Chronic administration of Etonogestrel (ETO) to adult female rats.
  • Assessment of respiratory function using whole-body plethysmography.
  • Measurement of PHOX2B mRNA and protein expression in key brain regions, including the dorsal vagal complex and solitary tract nucleus (NTS).

Main Results:

  • ETO treatment enhanced chemoreflex response and increased breathing cycle variability at rest.
  • ETO selectively reduced PHOX2B mRNA and protein expression in the dorsal vagal complex, particularly within the NTS.
  • Histological analysis indicated that the NTS is a primary site of ETO's action.

Conclusions:

  • The potent progestin Etonogestrel modulates respiratory control in vivo, potentially by targeting the NTS.
  • Reduced PHOX2B expression in the NTS is implicated in ETO's amelioration of respiratory dysfunction.
  • The NTS is a key candidate region for ETO-induced respiratory modulation in CCHS.